Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Perspective

The Complex Relationship Between Diabetes and Cardiac Arrhythmias: Pathophysiology and Mechanisms

Author(s): Michael Spartalis*, Panteleimon Pantelidis, Christos Kontogiannis, Stavroula A. Paschou, Eleftherios Spartalis, Dimitrios C. Iliopoulos and Gerasimos Siasos

Volume 28, Issue 26, 2022

Published on: 01 August, 2022

Page: [2129 - 2130] Pages: 2

DOI: 10.2174/1381612828666220720095433

conference banner
Abstract

Coronary artery disease, autonomic neuropathy, and diabetic cardiomyopathy are the most common cardiovascular complications of diabetes. However, emerging evidence demonstrates that diabetes also affects the heart’s electrical conduction system, culminating in lethal arrhythmias and sudden cardiac death. Diabetes and rhythm disturbances have a complex relationship, and arrhythmias cannot only be attributed to ischemia and autonomic neuropathy. Hypoglycemia, hyperglycemia, and glucose fluctuations can potentially induce arrhythmias by activating various pathways. Structural remodeling can accelerate and exacerbate disease development. Mitochondrial dysfunction can also alter the structure and metabolism of cardiomyocytes and contribute to disease progression through oxidative stress and inflammation.

Keywords: Diabetes mellitus, arrhythmias, cardiovascular, sudden cardiac death, fibrosis, substrate.

[1]
Rajbhandari J, Fernandez CJ, Agarwal M, Yeap BXY, Pappachan JM. Diabetic heart disease: A clinical update. World J Diabetes 2021; 12(4): 383-406.
[http://dx.doi.org/10.4239/wjd.v12.i4.383] [PMID: 33889286]
[2]
Grisanti LA. Diabetes and arrhythmias: Pathophysiology, mechanisms and therapeutic outcomes. Front Physiol 2018; 9: 1669.
[http://dx.doi.org/10.3389/fphys.2018.01669] [PMID: 30534081]
[3]
Liu H, Zhao Y, Xie A, et al. Interleukin-1β, oxidative stress, and abnormal calcium handling mediate diabetic arrhythmic risk. JACC Basic Transl Sci 2021; 6(1): 42-52.
[http://dx.doi.org/10.1016/j.jacbts.2020.11.002] [PMID: 33532665]
[4]
Stoll L, Lo JC. Is IL-1 the bridge connecting type 2 diabetes and cardiac arrhythmias? JACC Basic Transl Sci 2021; 6(1): 53-4.
[http://dx.doi.org/10.1016/j.jacbts.2020.12.003] [PMID: 33533755]
[5]
Spartalis M, Tzatzaki E, Paschou SA, Spartalis E. Type 1 diabetes is associated with increased risk of atrial fibrillation. Int J Cardiol 2019; 279: 114.
[http://dx.doi.org/10.1016/j.ijcard.2018.09.016] [PMID: 30527347]
[6]
Moris D, Spartalis M, Spartalis E, et al. The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox. Ann Transl Med 2017; 5(16): 326.
[http://dx.doi.org/10.21037/atm.2017.06.27] [PMID: 28861423]
[7]
Moris D, Spartalis M, Tzatzaki E, et al. The role of reactive oxygen species in myocardial redox signaling and regulation. Ann Transl Med 2017; 5(16): 324.
[http://dx.doi.org/10.21037/atm.2017.06.17] [PMID: 28861421]
[8]
Aune D, Schlesinger S, Norat T, Riboli E. Diabetes mellitus and the risk of sudden cardiac death: A systematic review and meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 2018; 28(6): 543-56.
[http://dx.doi.org/10.1016/j.numecd.2018.02.011] [PMID: 29730085]
[9]
Lynge TH, Svane J, Pedersen-Bjergaard U, et al. Sudden cardiac death among persons with diabetes aged 1-49 years: A 10-year nationwide study of 14 294 deaths in Denmark. Eur Heart J 2020; 41(28): 2699-706.
[http://dx.doi.org/10.1093/eurheartj/ehz891] [PMID: 31848583]
[10]
Paschou SA, Siasos G. Diabetes and the heart: New clinical trials and recent recommendations. Curr Pharm Des 2020; 26(37): 4685-6.
[http://dx.doi.org/10.2174/138161282637200925102942] [PMID: 33131468]

© 2024 Bentham Science Publishers | Privacy Policy